SEC Tracker
Get the app

Pulmatrix PULM

Pulmatrix reports interim data from PTC-2105 study

Merger communication

Form
425
Filed
Importance
Routine
  1. Interim results show preserved motor performance in aged rats
  2. Fat mass decreased 14.5% with PTC-2105 12.5 mg/kg
  3. Study conducted at Einstein's BIO-VITAL facility
  4. First-in-human trials targeted for 2027

Written from the 425 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Pulmatrix files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Curis CRIS public float $25M, Jun 30, 2025
  2. Scynexis SCYX public float $26M, Jun 30, 2025
  3. Palatin Technologies PTN public float $26M, Dec 31, 2025
  4. Kala Bio KALA public float $25M, Jun 30, 2025
  5. Lexaria Bioscience LEXX public float $25M, Feb 28, 2025, over 18 months old